Charlotta Ljungqvist

GE Healthcare AB wholesales and distributes pharmaceutical products. It promotes contrast agents for X-rays, magnetic resonance imaging, ultrasound and radiopharmaceuticals, use to predict and diagnose early-stage diseases. The company was founded on October 21, 1983 and is headquartered in Danderyd, Sweden.

Bioprocess Innovation Center develops biopharmaceutical products. The CEO of the Swedish company is Charlotta Ljungqvist.

The American Chamber of Commerce in Sweden was founded in 1992 and operates as a chamber of commerce. The non-profit company is based in Stockholm, Sweden.

VINNOVA AB provides funding services and financial assistance. It promotes collaborations between companies, universities, research institutes and the public sector. The company was founded in January 2001 and is headquartered in Stockholm, Sweden.

Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden.

Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill.

IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies.

Cytiva Testa Center AB is a Swedish company that provides an open and friendly testbed for biological production. The private company is based in Uppsala, Sweden. The company offers hands-on training, digital applications, and access to bioprocessing labs, equipment, and expertise to help ensure the success of your project. The company was founded in 2018, and the CEO is Jesper Hedberg.

Science for Life Laboratory, also known as scilifelab, is a national resource in Sweden that provides unique technologies and expertise to life scientists. The private company is based in Solna, Sweden. The Swedish company is closely connected to a community of researchers in various fields such as biomedicine, ecology, and evolution.

NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023.

BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.

Part of Danaher Corp., Global Life Sciences Solutions USA LLC is a company that manufactures therapeutics. The company is based in Marlborough, MA.